Combining DNA Damaging Agents and Checkpoint 1 Inhibitors

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)


Volume 16, 12 Issues, 2016


Download PDF Flyer




Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Combining DNA Damaging Agents and Checkpoint 1 Inhibitors



Anti-Cancer Agents in Medicinal Chemistry, 4(5): 435-438.

Author(s): Michelle Prudhomme.

Affiliation: Universite Blaise Pascal, Laboratoire Synthese et Etude de Systemes a Interet Biologique, UMR 6504du CNRS, 63177 Aubiere, France.

Abstract

During the cell cycle that leads to mitosis, checkpoints are activated in response to DNA damage. The checkpoints control the ability of cells to arrest the cell cycle allowing time to repair the DNA. In more than 50% of cancer cells, the G1 checkpoint is inactive due to mutations of p53. Therefore, the combination of a DNA damaging agent with a G2 checkpoint inhibitor should force selectively cancer cells into a premature and lethal mitosis. This approach which has recently drawn considerable interest is discussed in this paper.

Keywords:

dna damaging agents, checkpoint 1 inhibitors, g2 checkpoint inhibitor, mitosis.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 4
Issue Number: 5
First Page: 435
Last Page: 438
Page Count: 4
DOI: 10.2174/1568011043352795
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science